Granulocyte function in elderly patients receiving chemotherapy for aggressive non-Hodgkin's lymphoma - Effect of granulocyte colony-stimulating factor

European Journal of Internal Medicine

Volumn 13, Issue 7, 2002, Pages 448-454

  Ösby, Eva ^a   Björkholm, Magnus ^a   Lundahl, Joachim ^a   Forslid, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD11b; CD16; Chemotherapy; G CSF; Granulocyte; NHL

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORESCEIN DERIVATIVE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MITOXANTRONE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CELL LEVEL; CELL STIMULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE FUNCTION; GRANULOCYTOPENIA; HOSPITALIZATION; HUMAN; HUMAN CELL; INFECTION; LEUKOCYTE COUNT; LEUKOCYTE METABOLISM; MALE; METABOLIC ACTIVATION; NONHODGKIN LYMPHOMA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0036791055     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00137-1     Document Type: Article

References (34)

1. Dixon D.O., Neilan B., Jones S.E., et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group Experience. J Clin Oncol. 4:1986;295-305.
2. Tirelli U., Zagonel V., Serraino D., et al. Non-Hodgkin's lymphomas in 137 patients aged 70 years of older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study. J Clin Oncol. 6:1988;1708-1713.
3. Celsing F., Widell S., Merk K., et al. Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma. Ann Oncol. 11:1998;1213-1217.
4. Pettengell R., Gurney H., Radford J.A., et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non Hodgkin's lymphoma: A randomised controlled trial. Blood. 80:1992;1430-1436.
5. Bertini M., Freilone R., Vitolo U., et al. P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL). Ann Oncol. 5:1994;895-900.
6. Zagonel V., Babare R., Merola M.C., et al. Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy. Ann Oncol. 5:1994;127-132.
7. Zinzani P.L., Pavone E., Storti S., et al. Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. Blood. 89:1997;3974-3979.
8. Björkholm M., Ösby E., Hagberg H., et al. Randomized trial of r-metHu granulocyte colony-stimulating factor (G-CSF) as adjunct to CHOP or CNOP treatment of elderly patients with aggressive non-Hodgkin's lymphoma. Abstract no. 2665. 1999;American Society of Hematology.
9. Doorduijn J.K., van der Holt B., Buijt I., et al. Prophylactic granulocyte-colony stimulating factor (G-CSF) added to CHOP in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma (NHL). Final results of a multicenter phase 3 study. Proceedings of the 8th international conference on malignant lymphoma, Lugano, Switzerland. 2002;. Abstract no. 083.
10. Lieschke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). New Engl J Med. 327:1992;99-106.
11. Harmenberg J., Höglund M., Hellström-Lindberg E. G- and GM-CSF in oncology and oncological hematology. Eur J Haematol. 52:1994;1-28.
12. Price T.H., Chatta G.S., Dale D.C. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood. 88:1996;335-340.
13. Mazzone A., Ricevuti G. Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologica. 80:1995;161-175.
14. Kusunoki T., Tsuruta S., Higashi H., et al. Involvement of CD11b/CD18 in enhanced neutrophil adhesion by Fc gamma receptor stimulation. J Leukoc Biol. 55:1994;735-742.
15. Zhou M.J., Brown E.J. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fcgamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation. J Cell Biol. 125:1994;1407-1416.
16. Babior B.M., Kipnes R.S., Curnutte J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 52:1973;741-744.
17. Lennert K., Feller A. Histopathology of non-Hodgkin's lymphoma. 2nd ed. New York: Springer, 1992
18. Fearon D.T., Collins L.A. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J. Immunol. 130:1983;370-375.
19. Hed J., Berg O., Forslid J., Halldén G., Lärka-Rafner G. The expression of CR1 and CR3 on non-modulated and modulated granulocytes of healthy blood donors as measured by flow cytometry. Scand. J. Immunol. 28:1988;339-344.
20. Bass D.A., Parce J.W., DeChatelet L.R., Szejda P., Seeds M.C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils; a graded response to membrane stimulation. J. Immunol. 130:1983;1910-1917.
21. Carulli G., Azzará A., Minnucci S., Angiolini C., Sbrana S., Ambrogi F. fMLP-induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony-stimulating factor. J Exp Clin Cancer Res. 16:1997;301-308.
22. Spiekermann K., Emmendoerfer A., Elsner J., et al. Altered surface marker expression and function of G-CSF induced neutrophils from test subjects and patients under chemotherapy. Br J Haematol. 87:1993;31-38.
23. Ohsaka A., Saionji K., Kuwaki T., Takeshima T., Igari J. Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes. Br J Haematol. 89:1995;465-472.
24. Håkansson L., Höglund M., Jönsson U.-B., Torsteinsdottir I., Xu X., Venge P. Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion. Br J Haematol. 98:1997;603-611.
25. Carulli G., Minnucci S., Azzará A., et al. Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FcRII) expression and FcR-related functions. Haematologica. 80:1995;150-154.
26. Engervall P., Lundahl J. Alterations in adhesion molecule (CD11b/CD18 and CD62L) expression on granulocytes after chemotherapy. Eur J Clin Invest. 28:1998;924-929.
27. Blackwood R.A., Hartiala K.T., Kwoh E.E., Transue A.T., Brower R.C. Unidirectional heterologous receptor desensitisation between both the fMLP and C5a receptor and the IL-8 receptor. J Leucocyte Biol. 60:1996;88-93.
28. De Haas M., Kleijer M., van Zwieten R., Roos D., von dem Borne A. Neutrophil FcγRIIIb deficiency, nature and clinical consequences: a study of 21 individuals from 14 families. Blood. 86:1995;2403-2413.
29. Glasser L., Fiederlein R.L. Functional differentiation of normal human neutrophils. Blood. 69:1987;937-944.
30. Kansas G.S., Muirhead M.J., Dailey M.O. Expression of the CD11/CD18, leukocyte adhesion molecule 1 and CD 44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood. 76:1990;2483-2492.
31. Fujimoto H., Sakata T., Hamaguchi Y., et al. Flow cytometric method for enumeration and classification of reactive immature granulocyte populations. Cytometry. 42:2000;371-378.
32. Steele R.W., Steele C.R., Pilkington N.S. Jr., Charlton R. Functional capacity of marginated and bone marrow reserve granulocytes. Infect Immun. 55:1987;2359-2363.
33. Nakagawa M., Terashima T., D'yachkova Y., Bondy G.P., Hogg J.C., van Eeden S.F. Glucocorticoid-induced granulocytosis. Contribution of marrow release and demargination of intravascular granulocytes. Circulation. 98:1998;2307-2313.
34. Liles W.C., Huang J.E., Llewellyn C., SenGupta D., Price T.H., Dale D.C. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilisation of neutrophils in the peripheral blood of normal volunteers. Transfusion. 37:1997;182-187.